Nuclear data for medical radionuclides

Qaim, S.M.

doi:10.1007/s10967-014-3923-2

Cited by 35 publications

(29 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nuclear reactions induced by fast neutrons, fast photons as well as 10 -40 MeV protons and deuterons have been investigated (for recent reviews cf. [9,10]). Nuclear data for some reactions are known [cf.…”

Section: Diagnostic Radionuclidesmentioning

confidence: 99%

“…The production data of non-standard positron emitters have been discussed in detail in recent reviews [9,20]. In this article, therefore, only a few salient features are considered.…”

Section: Non-standard Positron Emittersmentioning

confidence: 99%

“…In two recent reviews the status of decay and production data of some important emerging therapeutic radionuclides has been discussed [cf. 9,10]. The scope of this article is therefore limited to only a few important features related to the three groups of radionuclides, namely low-energy β − emitters, α-emitters and very low-energy electron emitters.…”

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 99%

See 2 more Smart Citations

Nuclear data for medical applications: An overview of present status and future needs

Syed

2017

EPJ Web Conf.

View full text Add to dashboard Cite

Abstract.A brief overview of nuclear data required for medical applications is given. The major emphasis is on radionuclides for internal applications, both for diagnosis and therapy. The status of the presently available data is discussed and some of the emerging needs are outlined. Most of the needs are associated with the development of non-standard positron emitters and novel therapeutic radionuclides. Some new developments in application of radionuclides, e.g. theranostic approach, multimode imaging, radionanoparticles, etc. are described and the related nuclear data needs are discussed. The possible use of newer irradiation technologies for medical radionuclide production, e.g. intermediate energy charged-particle accelerators, high-power electron accelerators for photon production, and spallation neutron sources, will place heavy demands on nuclear data.

show abstract

Section: Diagnostic Radionuclidesmentioning

confidence: 99%

“…The production data of non-standard positron emitters have been discussed in detail in recent reviews [9,20]. In this article, therefore, only a few salient features are considered.…”

Section: Non-standard Positron Emittersmentioning

confidence: 99%

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 99%

See 1 more Smart Citation

Nuclear data for medical applications: An overview of present status and future needs

Syed

2017

EPJ Web Conf.

View full text Add to dashboard Cite

show abstract

“…The nuclear routes and production technologies for radionuclides commonly used in diagnosis and internal radiotherapy are generally well established . Nonetheless, constant research work is ongoing to improve the existing production methodologies of some established radionuclides as well as to develop novel radionuclides for new medical applications.…”

Section: Introductionmentioning

confidence: 99%

Development of novel radionuclides for medical applications

Qaim

Spahn

2017

Labelled Comp Radiopharmac

Self Cite

View full text Add to dashboard Cite

Medical radionuclide production technology is well established. There is, however, a constant need for further development of radionuclides. The present efforts are mainly devoted to nonstandard positron emitters (eg, Cu, Y, I, and Se) and novel therapeutic radionuclides emitting low-range β particles (eg, Cu and Re), conversion or Auger electrons (eg, Sn and Br), and α particles (eg, Ac). A brief account of various aspects of development work (ie, nuclear data, targetry, chemical processing, and quality control) is given. For each radionuclide under consideration, the status of technology for clinical scale production is discussed. The increasing need of intermediate-energy multiple-particle accelerating cyclotrons is pointed out.

show abstract

“…www.cern.ch/ntof a e-mail: gunsing@cea.fr of these levels are a crucial input to nuclear level density models. Finally, neutron-induced reaction cross sections are a key ingredient for the safety and criticality assessment of nuclear technology, including research on medical applications [9], radiation dosimetry, the transmutation of nuclear waste, accelerator-driven systems, future reactor systems as in Generation IV, and nuclear fuel cycle investigations [10][11][12].…”

Section: Introductionmentioning

confidence: 99%

Nuclear data activities at the n_TOF facility at CERN

et al. 2016

View full text Add to dashboard Cite

Abstract. Nuclear data in general, and neutron-induced reaction cross sections in particular, are important for a wide variety of research fields. They play a key role in the safety and criticality assessment of nuclear technology, not only for existing power reactors but also for radiation dosimetry, medical applications, the transmutation of nuclear waste, accelerator-driven systems, fuel cycle investigations and future reactor systems as in Generation IV. Applications of nuclear data are also related to research fields as the study of nuclear level densities and stellar nucleosynthesis. Simulations and calculations of nuclear technology applications largely rely on evaluated nuclear data libraries. The evaluations in these libraries are based both on experimental data and theoretical models. Experimental nuclear reaction data are compiled on a worldwide basis by the international network of Nuclear Reaction Data Centres (NRDC) in the EXFOR database. The EXFOR database forms an important link between nuclear data measurements and the evaluated data libraries. CERN's neutron time-of-flight facility n TOF has produced a considerable amount of experimental data since it has become fully operational with the start of the scientific measurement programme in 2001. While for a long period a single measurement station (EAR1) located at 185 m from the neutron production target was available, the construction of a second beam line at 20 m (EAR2) in 2014 has substantially increased the measurement capabilities of the facility. An outline of the experimental nuclear data activities at CERN's neutron time-of-flight facility n TOF will be presented.

show abstract

Nuclear data for medical radionuclides

Cited by 35 publications

References 77 publications

Nuclear data for medical applications: An overview of present status and future needs

Nuclear data for medical applications: An overview of present status and future needs

Development of novel radionuclides for medical applications

Nuclear data activities at the n_TOF facility at CERN

Contact Info

Product

Resources

About